Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
early-onset schizophrenia spectrum (EOSS) disorder
Eating disorders anorexia nervosa atypical/eating disorders not otherwise specified bulimia nervosa/binge eating disorder comorbid depression Eating disorders NICE guidelines
ECG changes, antiretrovirals
ECT augmentation
EEG test
Efavirenz, psychiatric adverse reactions
Effectiveness
Effect of antidepressants on glucose homeostasis and weight
Effect of psychotropic drugs on seizure during electroconvulsive therapy
Effect of smoking on psychotropic drugs
Effects of antipsychotic medication on prolactin concentration
Effects of psychotropics on CYP function
Efficacy Dementia efficacy for negative symptoms
Elderly people atrial fibrillation genitourinary symptoms of menopause optimising lithium treatment for prophylaxis in bipolar disorder
electrocardiogram (ECG) monitoring antipsychotic medication users methadone users with QTc prolongation risk factors
Electroconvulsive therapy
electroconvulsive therapy (ECT) 108-110 adverse effects Alternatives to clozapine children and adolescents drug resistant depression treatment for catatonia in pregnancy managing behavioural and psychological symptoms of dementia psychotic depression treatment psychotropic drug combination
Electrolytes alcohol effects anorexia nervosa antipsychotic medication monitoring
embolic events, SSRIs decreasing risk
Emergency situations, rapid tranquilisation
Energy drinks, caffeine content
Environmental lithium, high levels inversely related to suicide and dementia at a population level
Eosinophilia
Eosinophils, psychotropic agent effects
Epilepsy Epilepsy learning difficulties comorbidity psychiatric comorbidities
Equivalent doses and sites of administration for Aristada
Equivalent doses of first-generation antipsychotic medications
Equivalent doses - risperidone-based long-acting injections
Erectile dysfunction
Erythrocyte sedimentation rate, psychotropic agent effects